Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information



20 Park Plaza
Suite 1200
Boston, MA, 02116


Managing Partner
Operations Team
Operating Team
Operating Team
Operations Team
Executive in Residence


RA Capital Management

RA Capital Management is an investment advisor based in Boston specializing in the life-sciences and drug development sectors. Their team has been investing since 2002 and is comprised of professionals with training in biology, chemistry, and medicine and also has industry and business development experience at the executive and board levels. They invest in companies with promising technologies and products. Their approach is to achieve a superior understanding of data, experimental/trial design, regulatory process, and commercial potential. When appropriate, they can offer their portfolio companies leads on in-licensing opportunities and strategic partnerships, as well as insight into the demands of the public markets.

Recent Milestones


Company Date Round Size Participants
Intarcia Therapeutics 4/2014Private Equity$200M6
pSivida 3/2014Post IPO Equity$7M1
Lumena Pharmaceuticals 3/2014Series B$45M6
ZS Pharma 3/2014Series D$55M9
Aurinia Pharmaceuticals 2/2014Post IPO Equity$52M9
Zipline Medical 1/2014Series C$4.3M3
Zafgen 12/2013Series E$45M4
Ocera Therapeutics 11/2013Venture Round$28M8
Arrowhead Research 10/2013Post IPO Equity$60M1
Civitas Therapeutics 9/2013Series B$38M6
Dicerna Pharmaceuticals 7/2013Series C$60M9
AmpliPhi Biosciences 7/2013Private Equity$12.5M3
bluebird bio 7/2012Series D$60M7
CellScape 7/2012Venture Round$1.1M2
OvaScience 4/2012Series B$37M5
T2 Biosystems 8/2011Series D$23M10
ADVENTRX Pharmaceuticals 1/2011Venture Round$22.5M1
T2 Biosystems 5/2010Series C$15M9
Genelabs Technologies 6/2006Venture Round$8.3M5



  1. Intarcia Therapeutics Raises $200m Financing ( [edit]
  2. pSivida Corp. Announces $7.0 Million Investment by RA Capital ( [edit]
  3. Lumena Pharmaceuticals Secures $45M in Series B Financing ( [edit]
  4. ZS Pharma Completes $55 Million Financing to Advance Its Novel Investigational Treatment for Hyperkalemia ( [edit]
  5. Aurinia Announces US$52 Million Private Placement ( [edit]
  6. ZipLine Medical Closes $4.3M Series C Financing ( [edit]
  7. Zafgen Secures $45M in Series E Equity Financing ( [edit]
  8. Ocera raises $28M for PhIIb liver disease study Read more: Ocera raises $28M for PhIIb liver disease study - FierceBiotech Subscribe at FierceBiotech ( [edit]
  9. Arrowhead Research Raises $60M In PIPE ( [edit]
  10. Civitas Therapeutics Completes $38M Series B Financing ( [edit]
  11. Dicerna Pharmaceuticals Raises $60M In Series C Financing ( [edit]
  12. SEC ( [edit]
  13. bluebird bio Secures $60 Million in Oversubscribed Financing ( [edit]
  14. VC Funding: Q3 2012 source [edit]
  15. OvaScience grabs $37M B round for fertility treatments ( [edit]
  16. T2 Biosystems closes $23M Series D financing ( [edit]
  17. Adventrx announces $22.5M capital raise ( [edit]
  18. T2 Biosystems, Inc.: Series C $15M ( [edit]
  19. EDGAR [edit]
Edit This Page
Last Edited 4/2/14

Revision History RSS Picture


Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize ยป

External Links

CrunchBase API


Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy